Volume: 17 Issue: 11

1. Evaluation of current imaging in restaging rectal cancer after neoadjuvant therapy. Page:1156—1160
2. Neoadjuvant chemotherapy for colon cancer based on evidence-based medicine. Page:1151—1155
3. Mechanism exploration and future prospects of antiangiogenic agents improving tumor blood supply and oxygenation. Page:1148—1151
4. Detection of CDH1 gene methylation of suspension cells in abdominal lavage fluid from colorectal cancer patients and its clinical significance. Page:1133—1136
5. Genomics analysis of miRNA in colon cancer tissues. Page:1130—1132
6. Management of colonic injuries in the setting of damage control surgery. Page:1125—1129
7. Application of three-dimensional laparoscopic system in obturator lymph node dissection of progressive rectal cancer. Page:1121—1124
8. Application of right-to-lateral approach in laparoscopic-assisted radical gastrectomy. Page:1115—1120
9. Application study of totally laparoscopic distal gastrectomy with delta-shaped anastomosis. Page:1111—1114
10. Extralevator abdominoperineal excision versus traditional abdominoperineal excision in the treatment of low rectal cancer. Page:1106—1110
11. Function of death associated protein kinase(DAPK) in colorectal cancer chemoresistance. Page:1101—1105
12. Expression of long non-coding RNA associated with radiotherapy-resistance in colorectal cancer cell lines with different radiosensitivity. Page:1096—1100
13. Application of regional arterial infusion chemotherapy in short-term neoadjuvant chemotherapy for advanced gastric cancer. Page:1092—1095
14. Safety and efficacy of intraperitoneal hyperthermic perfusion chemotherapy following laparoscopic palliative resection for gastric cancer patients with peritoneal metastasis. Page:1087—1091
15. Safety and efficacy analysis on modified FOLFOXIRI as first-line treatment for advanced colorectal cancer in China-single center experience. Page:1081—1086
16. Anatomical key points and operative principle of "two planes and four landmarks" in extralevator abdominoperineal excision. Page:1076—1080
17. Timing of radiotherapy for locally advanced rectal cancer. Page:1072—1075
18. Treatment choice of locally advanced low and middle rectal cancer after neoadjuvant chemoradiation. Page:1068—1071
19. Application of molecular targeted agents in comprehensive treatment of gastrointestinal cancer. Page:1062—1067
20. Establishment and promotion of multi-disciplinary treatment for colorectal liver metastases. Page:1060—1061
21. Further recognition and improvement of multimodality treatment for advanced gastric cancer. Page:1051—1059